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che recommendations of this Joint Task Force, made up of
epresentatives of the American College of Cardiology Foun-
ation (ACCF) and the American Society of Nuclear Cardi-
logy (ASNC), have been approved by the governing bodies of
he ACCF and the ASNC in January 2006.
RAINING IN NUCLEAR CARDIOLOGY
uclear cardiology (Table 1) provides important diagnostic
nd prognostic information that is an essential part of the
nowledge base required of the well-trained cardiologist for
ptimal management of the cardiovascular patient. Training
f fellows in nuclear cardiology is divided into three levels:1
General (Level 1, 2 months): makes trainee conversant
with the field of nuclear cardiology for application in
general clinical management of cardiovascular patients.
Specialized (Level 2, 4 to 6 months): provides trainee with
special expertise to practice clinical nuclear cardiology.
Advanced (Level 3, 1 year): provides advanced training
sufficient to pursue an academic career or direct a nuclear
cardiology laboratory.
eneral Cardiology Training Background
o have an adequate understanding of the clinical applica-
ions of nuclear cardiology and to perform tests safely, the
ardiology trainee must acquire knowledge and proficiency
n the following areas of general cardiology:
. Coronary angiography and physiology
. Cardiac physiology and pathophysiology
. Rest and exercise electrocardiography
. Exercise physiology
. Pharmacology of standard cardiovascular drugs
. Cardiopulmonary resuscitation and treatment of other
cardiac emergencies
. Pharmacology and physiology of commonly used stress
agents, such as dipyridamole, adenosine, and dobutamine
. Clinical outcomes assessment
The issues of ongoing clinical competence and training or retraining of practicing
ardiologists are beyond the scope of this document. The Certification Board of
uclear Cardiology (CBNC) was established jointly by the ACC and ASNC and
ssesses knowledge and mastery in the areas of radiation safety and the technical and
linical performance of nuclear cardiology procedures. For additional information,p
ontact CBNC at 19562 Club House Road, Montgomery Village, Maryland 20886.
ttp://www.cbnc.org.verview of Nuclear Cardiology Training
raining in nuclear cardiology at all levels should provide an
nderstanding of the indications for specific nuclear cardi-
logy tests, the safe use of radionuclides, basics of instru-
entation and image processing, methods of quality con-
rol, image interpretation, integration of risk factors, clinical
ymptoms, and stress testing, and the appropriate applica-
ion of the resultant diagnostic information for clinical
anagement. The depth of understanding will vary with
ach of the three levels of training. Training in nuclear
ardiology is best acquired in Accreditation Council for
raduate Medical Education (ACGME) approved training
rograms in cardiology, nuclear medicine, or radiology. An
xception to this ACGME requirement is the didactic and
aboratory training in radiation safety and radioisotope
andling that may be provided by qualified physicians/
cientists in a non-ACGME program when such a program
s not available as part of the clinical ACGME training
rogram.
Nuclear cardiology training consists of the components
hown in Table 2. Didactic, clinical case experience, and
ands-on training hours require documentation in a log-
ook, having the trainee’s name appear on the clinical
eport, or having some other specific record. The hours need
o be monitored and verified by the nuclear cardiology
raining preceptor. For the advanced trainee, specialized
raining and research can be derived as part of an established
rogram in either cardiology or a division of nuclear
edicine. The person(s) responsible for the didactic, clini-
al, and hands-on training and experience are responsible
or evaluating the competence of the trainee in nuclear
ardiology upon completion of the program. This can be
ccomplished by observing the daily performance of the
ellow, a formal testing procedure, or both. The preceptor
or specialized or advanced training should have Level 3 (or
he equivalent) training in nuclear cardiology.
idactic Program
ectures and self-study. This component is composed of
ectures on the basic aspects of nuclear cardiology and
arallel self-study material consisting of reading and viewing
ases on video or CD. The lectures and reading should
rovide the fellow with an understanding of the clinical
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February 21, 2006:898–904 Task Force 5: Training in Nuclear Cardiologypplications of nuclear cardiology, including imaging with
ositron-emitting radionuclides and computed tomography
CT) hybrid systems including single-photon emission
omputed tomography (SPECT)/CT and positron emis-
ion tomography (PET)/CT. The material covered should
nclude radiopharmaceuticals, radiation physics instrumen-
ation, nuclear cardiology diagnostic tests, and procedures/
rotocols, general cardiology as it relates to image interpre-
ation, risk stratification, myocardial perfusion imaging,
entricular function imaging, and assessment of myocardial
iability. Specificity, sensitivity, diagnostic accuracy, utility
n assessing prognoses and interventions, costs, indications,
nd pitfalls in interpretation and clinical application must be
mphasized for each patient subset.
This program may be scheduled over a 12- to 24-month
eriod, concurrent with other fellowship assignments. Some
f the information can be effectively transmitted as part of a
eekly non-invasive or invasive cardiology conference with
resentation and discussion of nuclear cardiology image
ata.
adiation safety. The second component of the didactic
rogram should provide the fellow with an understanding of
adiation safety as it relates to patient selection and admin-
stration of radiopharmaceuticals and utilization of CT
ystems. Fellows seeking Level 2 or Level 3 training will
equire greater in-depth knowledge as well as hands-on
ractical experience. These are detailed for each level.
nterpretation of Clinical Cases
uring training, fellows should actively participate in daily
uclear cardiology study interpretation under the direction
able 1. Classification of Nuclear Cardiology Procedures
. Standard nuclear cardiology procedures
a. Myocardial perfusion imaging
i. SPECT with technetium-99m agents and thallium-201
ii. PET with rubidium-82 and nitrogen-13 ammonia
iii. Planar with technetium-99m agents and thallium-201
iv. ECG gating of perfusion images for assessment of global and
regional ventricular function
v. Imaging protocols
vi. Stress protocols
1. Exercise stress
2. Pharmacologic stress
vii. Viability assessment including reinjection and delayed
imaging of thallium-201 and metabolic imaging where
available
b. Equilibrium gated blood pool or “first pass” radionuclide
angiography at rest and during exercise or pharmacologic stress
c. Qualitative and quantitative methods of image display and
analysis
. Less commonly used nuclear cardiology procedures
a. Combined myocardial perfusion imaging with cardiac CT
b. Metabolic imaging using single-photon and/or positron-emitting
radionuclides
c. Myocardial infarct imaging
d. Cardiac shunt studies
T  computed tomography; ECG  electrocardiographic; PET  positron
mission tomography; SPECT  single-photon emission computed tomography.f a qualified preceptor in nuclear cardiology. For all studiesn which angiographic or hemodynamic data are available,
uch information should be correlated with the nuclear
ardiology studies. Although experience in all aspects of
uclear cardiology is recommended, some procedures may
ot be available—or may be performed in low volume—in
ome training programs. Under such circumstances, an
dequate background for general fellowship training can be
atisfied with appropriate reading or review of case files.
raining in nuclear cardiology needs to include extensive
xperience with the standard nuclear cardiology procedures
nd as much exposure as possible to the less commonly
erformed procedures. The training program needs to
rovide a teaching file consisting of perfusion and ventric-
lar function studies with angiographic documentation of
isease.
ands-On Experience
linical cases. Fellows should have hands-on supervised
xperience in an appropriate number of the standard proce-
ures (e.g., myocardial perfusion imaging and radionuclide
ngiography) and as many of the less commonly performed
rocedures as possible. Such experience should include pretest
atient evaluation; radiopharmaceutical preparation—
easuring the dose, administration, and experience with rele-
ant radionuclide generators; operation and quality control of
lanar and SPECT gamma camera and CT systems; setup of
he imaging computer; utilization of electrocardiogram (ECG)
ating; performing treadmill, bicycle, and pharmacologic stress
esting techniques; processing the data for display; interpreting
he study; and generating a clinical report. Complete nuclear
ardiology studies should be performed under the supervision
f qualified personnel.
adiation safety. Fellows need to be familiar with radia-
ion biology and the regulations governing the use of
adioactive materials and ionizing radiation for performing
iagnostic nuclear cardiology and hybrid CT studies. This
nowledge includes details for protecting patients, the
ublic, and the user from the effects of radiation.
ENERAL TRAINING—
EVEL 1 (MINIMUM OF 2 MONTHS)
he trainee is exposed to the fundamentals of nuclear
ardiology for a minimum period of 2 months during
raining. This 2-month experience provides familiarity with
uclear cardiology technology and its clinical applications in
he general clinical practice of adult cardiology, but it is not
ufficient for the specific practice of nuclear cardiology. The
able 2. Nuclear Cardiology Training Components
. Didactic program
a. Lectures and self-study
b. Radiation safety
. Interpretation of clinical cases
. Hands-on experience
a. Clinical cases
b. Radiation safety
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Task Force 5: Training in Nuclear Cardiology February 21, 2006:898–904hree components of training include a didactic program
hat includes lectures, self-study, radiation safety and regu-
ations, interpretation of nuclear cardiology studies, and
ands-on experience.
idactic Program
ectures and self-study. This component consists of lec-
ures on the basic aspects of nuclear cardiology and parallel
elf-study material consisting of reading and viewing case
les. The material presented should integrate the role of
uclear cardiology into total patient management. Such
nformation can be included within a weekly non-invasive or
nvasive cardiology conference, with presentation and dis-
ussion of nuclear cardiology image data as part of diagnos-
ic and therapeutic management.
nowledge and appreciation of radiation safety. The
idactic program should include reading and practical ex-
erience with the effects of radiation and provide the fellow
ith an understanding of radiation safety as it relates to
atient selection and administration of radiopharmaceuti-
als and utilization of CT systems.
nterpretation of Nuclear Cardiology Studies
uring the 2-month rotation, fellows should actively par-
icipate in daily nuclear cardiology study interpretation
minimum of 80 h). Experience in all the areas listed in
able 1 is recommended. If some procedures are not
vailable or are performed in low volume, an adequate
ackground for general fellowship training can be satisfied
y appropriate reading or review of case files. The teaching
le should consist of perfusion and ventricular function
tudies with angiographic/cardiac catheterization documen-
ation of disease.
ands-On Experience
ellows should perform complete nuclear cardiology studies
longside a qualified technologist or other qualified laboratory
ersonnel. They should, under supervision, observe and par-
icipate in a large number of the standard procedures and as
any of the less commonly performed procedures as possible.
ellows should have experience in the practical aspects of
adiation safety associated with performing clinical patient
tudies.
PECIALIZED TRAINING—
EVEL 2 (MINIMUM OF 4 MONTHS)
ellows who wish to practice the specialty of nuclear cardiology
re required to have at least 4 months of training. This includes
minimum of 700 h of didactic, clinical study interpretation
nd hands-on clinical case and radiation safety training in
uclear cardiology. In training programs with a high volume of
rocedures, clinical experience may be acquired in as short a
eriod as 4 months. In programs with a lower volume of
rocedures, a total of six months of clinical experience will be
ecessary to achieve Level 2 competency. The additional
s
araining required of Level 2 trainees is to enhance their clinical
kills and qualify them to become authorized users of radioac-
ive materials in accordance with the regulations of the Nuclear
egulatory Commission (NRC) and/or the agreement states.2
idactic Program
ectures and self-study. The didactic training should
nclude in-depth details of all aspects of the procedures
isted in Table 1. This program may be scheduled over a 12-
o 24-month period concurrent and integrated with other
ellowship assignments.
adiation safety. Classroom and laboratory training need
o include extensive review of radiation physics and instru-
entation, radiation protection, mathematics pertaining to
he use and measurement of radioactivity, chemistry of
yproduct material for medical use, radiation biology, the
ffects of ionizing radiation and radiopharmaceuticals.
here should be a thorough review of regulations dealing
ith radiation safety for the use of radiopharmaceuticals and
onizing radiation. This experience should total a minimum
f 80 h and be clearly documented.
nterpretation of Clinical Cases
ellows should participate in the interpretation of all nuclear
ardiology imaging data for the 4- to 6-month training
eriod. It is imperative that the fellows have experience in
orrelating catheterization or CT angiographic data with
adionuclide-derived data for a minimum of 30 patients. A
eaching conference in which the fellow presents the clinical
aterial and nuclear cardiology results is an appropriate
orum for such an experience. A total of 300 cases should be
nterpreted under preceptor supervision from direct patient
tudies (Table 3).
ands-On Experience
linical cases. Fellows acquiring Level 2 training should
ave hands-on supervised experience with a minimum of 35
atients: 25 patients with myocardial perfusion imaging and
0 patients with radionuclide angiography. Such experience
Level 2 and Level 3 training meet eligibility criteria for taking the Certification
oard of Nuclear Cardiology examination and NRC training and experience
equirements to become an authorized user. The NRC establishes federal policy with
egard to the medical use of nuclear reactor byproduct materials. Currently, there are
3 states that have applied and been approved by the NRC to self-regulate the use of
adioactive materials, so-called “agreement states.” The other 19 states are regulated
y the federal policy. There is variation within the agreement states in the training and
xperience requirements for physicians applying to become authorized users of
adioactive materials for diagnostic testing. The NRC requires only that the
greement state requirements be as stringent as the federal NRC policy, but states
ave the authority to make the requirements more stringent. Some states require a
reater number of total hours for the didactic, classroom, and laboratory experience in
adiation safety. Other states have restricted the acceptable programs or institutions
here such training hours may be acquired. Given this variability in training and
xperience requirements within the U.S., trainees are advised to contact the NRC and
he agreement states where they may seek to become authorized users of radioactive
aterials for the current rules and requirements. For details contact the agreement
tates’ homepage at http://www.hsrd.ornl.gov/nrc/home.html. Click on directory and
hen click on directory of agreement states and non-agreement state directors and
tate liaison officers. This will provide information on contacting the individual states
nd getting the specific licensure requirements.
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February 21, 2006:898–904 Task Force 5: Training in Nuclear Cardiologyhould include pre-test patient evaluation, radiopharmaceu-
ical preparation (including experience with relevant radio-
uclide generators and CT systems), performance of the
tudy, administration of the dosage, calibration, and setup of
he gamma camera and CT system, setup of the imaging
omputer, processing the data for display, interpretation of
he studies, and generating clinical reports.
adiation safety work experience. This experience should
e acquired continuously during training in the clinical
nvironment where radioactive materials are being used and
nder the supervision of an authorized user who meets the
RC requirements of Part 35.290 or Part 35.290(c)(ii)(G)
nd Part 35.390 or the equivalent agreement state require-
ents, and must include:
. Ordering, receiving, and unpacking radioactive materi-
als safely and performing the related radiation surveys;
. Performing quality control procedures on instruments
used to determine the activity of dosages and perform-
ing checks for proper operation of survey meters;
. Calculating, measuring, and safely preparing patient or
human research subject dosages;
. Using administrative controls to prevent a medical event
involving the use of unsealed byproduct material;
. Using procedures to safely contain spilled radioactive
material and using proper decontamination procedures;
. Administering dosages of radioactive material to patients
or human research subjects; and
. Eluting generator systems appropriate for preparation of
radioactive drugs for imaging and localization studies,
measuring and testing the eluate for radionuclide purity,
and processing the eluate with reagent kits to prepare
labeled radioactive drugs.
dditional Experience
he training program for Level 2 must also provide expe-
ience in computer methods for analysis. This should include
erfusion and functional data derived from thallium or tech-
etium agents and ejection fraction and regional wall motion
easurements from radionuclide angiographic studies.
ADVANCED TRAINING—
EVEL 3 MINIMUM OF 1 YEAR)
or fellows planning an academic career in nuclear cardiol-
gy or a career directing a clinical nuclear cardiology
aboratory, an extended program is required. This may be
art of the standard three-year cardiology fellowship. In
ddition to the recommended program for Level 2, the
evel 3 program should include advanced quality control of
uclear cardiology studies and active participation and
esponsibility in ongoing laboratory or clinical research. In
arallel with participation in a research program, the trainee
hould participate in clinical imaging activities for the total
raining period of 12 months, to include supervised inter-
retative experience in a minimum of 600 cases. Hands-on
xperience should be similar to, or greater than, that
*
iequired for Level 2 training. The fellow should be trained
n most of the following areas:
Qualitative interpretation of standard nuclear cardiology
tudies, including myocardial perfusion imaging, ECG-
ated perfusion studies, gated equilibrium studies, “first-
ass,” and any of the less commonly performed procedures
vailable at the institution
Quantitative analysis of perfusion and/or metabolic studies
Quantitative radionuclide angiographic and gated perfu-
sion analyses, including measurement of global and
regional ventricular function
SPECT perfusion acquisition, reconstruction, and display
ECG-gated SPECT perfusion acquisition, analysis, and
display of functional data
Imaging of positron-emitting tracers using either dedi-
cated PET systems or SPECT-like systems equipped
with either high-energy photon collimators or coinci-
dence detection
he requirements for Level 1 to 3 training in nuclear
ardiology are summarized in Table 3.
pecific Training in Cardiac
maging of Positron-Emitting Radionuclides
ardiac PET and PET/CT imaging of positron-emitting
adionuclides are part of nuclear cardiology. For institutions
hat have positron imaging devices, training guidelines are
ppropriate. Training in this particular imaging technology
hould go hand-in-hand and may be concurrent with
raining in conventional nuclear cardiology. Such training
hould include those aspects that are unique or specific to
he imaging of positron-emitting radionuclides. Depending
n the desired level of expertise, training in cardiac PET and
maging with positron-emitting radionuclides should in-
lude knowledge of substrate metabolism in the normal and
iseased heart; knowledge of positron-emitting tracers for
lood flow, metabolism and neuronal activity, medical cyclo-
rons, radioisotope production, and radiotracer synthesis; and
rinciples of tracer kinetics and their in vivo application for the
on-invasive measurements of regional metabolic and func-
ional processes. The training should also include the physics
f positron decay, aspects of imaging instrumentation spe-
ific to imaging of positron emitters and the use of CT,
roduction of radiopharmaceutical agents, quality control,
andling of ultrashort life radioisotopes, appropriate radia-
ion protection, and safety and regulatory aspects.
able 3. Summary of Training Requirements for
uclear Cardiology
evel
Minimum Duration
of Training Total No. of Examinations
1 2 months 80 h interpretative experience
2 4–6 months 300*
3 12 months 600*A minimum of 35 cases with hands-on experience must be performed and
nterpreted under supervision.
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Task Force 5: Training in Nuclear Cardiology February 21, 2006:898–904Consistent with the training guidelines for general nuclear
ardiology, training should be divided into three classes.
ENERAL TRAINING (2 MONTHS)
his level is for cardiology fellows who are associated with an
nstitution where PET and/or PET/CT devices are available and
ho wish to become conversant with cardiac positron imaging.
raining should therefore be the same as for Level 1 training in
uclear cardiology but should include aspects specific to cardiac
ositron imaging. The additional proficiency to be acquired by
hysician trainees includes background in substrate metabolism,
atient standardization, and problems related to diabetes mellitus
nd lipid disorders, positron-emitting tracers of flow, and metab-
lism and technical aspects of positron and CT imaging. A
idactic program should include the interpretation of cardiac PET
tudies of myocardial blood flow and substrate metabolism, the
nterpretation of studies combining SPECT for evaluation of
lood flowwith PET for evaluation ofmetabolism, the evaluation
f diagnostic accuracy and cost-effectiveness of viability assessment
f coronary artery disease detection, and the understanding of
adiation safety as specifically related to positron emitters.
ands-on experience should include supervised observation and
nterpretation of cardiac studies performedwith positron-emitting
adionuclides and PET and PET/CT imaging devices.
PECIALIZED TRAINING (MINIMUM OF 4 MONTHS)
his level of training is for fellows who wish to perform and
nterpret cardiac PET or positron-imaging studies in addi-
ion to nuclear cardiology. This training should include all
evel 1 and Level 2 training in nuclear cardiology (4 to 6
onths) as well as general training for cardiac PET and
ET/CT. Specific aspects of training for PET and for using
ositron-emitting radionuclides should include radiation
osimetry, radiation protection and safety, dose calibration,
hysical decay rates of radioisotopes, handling of large doses
f high energy radioactive materials of short physical half-
ives, quality assurance procedures, and NRC safety and
ecord-keeping requirements. This level of training requires
irect patient experience with a minimum of 40 patient
tudies of myocardial perfusion or metabolism, or both.
DVANCED TRAINING (MINIMUM 1 YEAR)
his level of training is intended for fellows planning an
cademic career in cardiac PET or who wish to direct a
linical cardiac PET laboratory. Similar to Level 3 training
n nuclear cardiology, this training should include active
articipation in laboratory and clinical research in parallel
ith clinical activities.
In addition to the requirements for general and special-
zed cardiac PET training (including standard nuclear cardi-
logy training, as previously described), advanced training
hould include the following:. Basic principles of cyclotrons, isotope production, ra-
diosynthesis, tracer kinetic principles and tracer kinetic
models, cardiac innervation and receptors, and methods
for quantifying regional myocardial blood flow and
substrate metabolism.
. Imaging instrumentation including dedicated PET sys-
tems, hybrid PET/CT systems, and SPECT-like positron
imaging devices with high-energy photon collimators or
coincidence detection. Image acquisition and processing
to include review of sinograms, errors in image recon-
struction, correction routines for photon attenuation,
and patient misalignment.
. Tissue kinetics of positron-emitting tracers; in vivo
application of tracer kinetic principles; tracer kinetic
models, generation of tissue time activity curves, and
computer-assisted calculation of region of functional
processes of the myocardium.
. Computer-assisted data manipulation, quantitative im-
age analysis, and image display.
ybrid CT Imaging
ybrid imaging devices combining PET or SPECT with
T are playing an increasing role in the field of cardiac
maging. Currently, nearly all PET scanners are sold as
ET/CT devices, and SPECT/CT machines are now
vailable from most manufacturers. As these devices become
ore widely disseminated, it will be important that training
uidelines for their use be developed both for fellows in
raining and cardiologists already in practice. The applica-
ions of hybrid imaging in cardiology include the use of CT
canning to provide robust attenuation correction of
PECT or PET and to assess coronary calcium as a marker
f coronary atherosclerosis. Even these non-contrast appli-
ations of hybrid imaging will require additional training
eyond that required for CT alone. With CT coronary
alcium and SPECT or PET perfusion assessments, addi-
ional training will be needed regarding discordant results.
ith contrast injection, high-resolution CT coronary an-
iography can be combined with rest/stress assessments of
yocardial perfusion provided by PET and SPECT, allow-
ng functional assessment of the anatomic findings. The
pecifics of the training required in hybrid imaging are
eyond the scope of this document; nonetheless, those
uclear cardiology training programs that are equipped to
erform hybrid imaging should incorporate training in this
eld in their programs. Training should include the physics
f hybrid systems, CT attenuation correction, principles
nd application of CT coronary calcium assessment,
nd principles and application of CT coronary angiography.
his is an update of the 2002 document that was written by
anuel D. Cerqueira, MD, FACC, Heinrich R. Schelbert,
D, PhD, FACC, Frans J. Th. Wackers, MD, PhD, FACC,
nd Mario Verani, MD, FACC.10.1016/j.jacc.2005.12.027
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elinical cardiac electrophysiology and cardiac pacing
ave merged into a common cardiac subspecialty disci-
line. Today, complex cardiac arrhythmias are managed
y physicians with special expertise in cardiac electro-
hysiology, the use of implantable pacemakers and im-
lantable cardioverter-defibrillators (ICDs), and the ap-
lication of other interventional techniques and
reatments. Non-pharmacologic therapy also includes
lectrophysiologic mapping and subsequent catheter or
urgical ablation as standard treatment for certain tachy-
rrhythmias. In addition, antiarrhythmic agents with
iverse mechanisms of action are often used therapeuti-
ally alone or in conjunction with cardiac implantable
lectrical devices.
In 1986, a Task Force 6 report on training in cardiac
acing (1) was published as a result of Bethesda Confer-
nce 17 on adult cardiology training. In 1991, a training
tatement recommending guidelines for training in adult
linical cardiac electrophysiology was published (2). In
995, a task force (3) combined these two closely related
isciplines to reflect the current merging of science, art,
nd the practice of clinical cardiac electrophysiology. In
002, updated recommendations were published (4). The
urrent task force is charged with updating these training
uidelines based on changes in the pacing and cardiac
lectrophysiology field since that time. AENERAL STANDARDS AND ENVIRONMENT
acilities and Faculty
hree organizations—the American College of Cardiology
ACC), the American Heart Association (AHA), and the Heart
hythm Society (HRS)—have addressed training requirements
nd guidelines for permanent pacemaker selection, implantation,
nd follow-up (5,6); guidelines for the implantation and follow-up
f ICDs in cardiovascular practice (7,8); guidelines for training in
atheter ablation procedures (9,10); and teaching objectives for
ellowship programs in clinical electrophysiology (11,12). The
raining recommendations for these three organizations are
ongruent and address new technologies, faculty, and facility
equirements, as well as practice. It is strongly recommended
hat trainees who desire admission to the American Board
f Internal Medicine (ABIM) examination for certification
n cardiovascular diseases and those who seek admission to
he Clinical Cardiac Electrophysiology (CCEP) examina-
ion for certification of added qualifications in clinical
ardiac electrophysiology be certain to obtain specific re-
uirements from the ABIM (13,14).
The cardiac arrhythmia aspects of a cardiology training
rogram should meet the published recommendations and
equirements regarding facilities and faculty (9,10). In order
or trainees to be eligible for admission to the CCEP
xamination of the ABIM, training must take place in an
ccreditation Council for Graduate Medical Education
